(Q40249082)

English

Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival

scientific article published on 26 November 2015

In more languages
default values for all languages
No label defined

No description defined

Statements

Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit